Drugs like Ozempic can boost the risk of some gastrointestinal problems in weight loss patients, compared to other weight loss drugs, a study has revealed for the first time—but the risk remains low.
American pharmaceutical company Eli Lilly plans to acquire cancer therapy firm Point Biopharma Global, the companies announced Tuesday, an expansion that comes as manu…
A strike at one of the nation’s largest healthcare organizations could kick off on Wednesday if union members don’t reach an agreement with Kaiser Permanente.
A new study from Columbia University researchers found that during higher temperatures, hospitals see a larger number of drug- and alcohol-related admissions—leading t…
Researchers with Mount Sinai Hospital and Yale University say they’re the first to identify specific blood biomarkers that can accurately identify long Covid—allowing …